Avencia Sánchez-Mejías
Directeur Général chez Integra Therapeutics SL
Postes actifs de Avencia Sánchez-Mejías
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Integra Therapeutics SL
 Integra Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Integra Therapeutics SL is a Spanish Barcelona-based company founded in 2020 by Marc Güell and Avencia Sánchez-Mejías, with Avencia Sánchez-Mejías serving as the CEO since then. The company is focused on engineering the next-generation of gene writing tools to cure genetic and oncological diseases with high unmet medical need. Integra Therapeutics is committed to creating new gene writing tools that improve the scope, efficiency, and safety of advanced therapies. | Directeur Général | - | - |
| Fondateur | - | - |
Historique de carrière de Avencia Sánchez-Mejías
Statistiques
Internationale
| Espagne | 2 |
Opérationnelle
| Chief Executive Officer | 1 |
| Founder | 1 |
Sectorielle
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Integra Therapeutics SL
Integra Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Integra Therapeutics SL is a Spanish Barcelona-based company founded in 2020 by Marc Güell and Avencia Sánchez-Mejías, with Avencia Sánchez-Mejías serving as the CEO since then. The company is focused on engineering the next-generation of gene writing tools to cure genetic and oncological diseases with high unmet medical need. Integra Therapeutics is committed to creating new gene writing tools that improve the scope, efficiency, and safety of advanced therapies. | Commercial Services |
- Bourse
- Insiders
- Avencia Sánchez-Mejías
- Expérience
